Douglas R Adkins

20PUBLICATIONS

188CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 31, 2026

Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study.

|Apr 01, 2026

Systemic Treatment of Thyroid Cancer: ASCO Guideline.

Nabil F Saba, Nofisat Ismaila, Douglas Adkins

|Feb 22, 2026

Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Jan 27, 2026

Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Nov 03, 2025

Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer.

Seka Lazare, Zhuosheng Gu, Noah Earland

|Aug 20, 2025

Olaparib, Pembrolizumab, and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase II Trial.

Douglas Adkins, Jessica C Ley, Jingxia Liu

Pageof 4

Frequent Collaborators

Sidharth V Puram

Patrik Pipkorn

Nofisat Ismaila

Barbara Burtness

Nabil F Saba

Ryan S Jackson

Wade Thorstad

Ralph J Hauke

Anthony W Tolcher

Jyoti Malhotra

Frequent Collaborators

Sidharth V Puram

Patrik Pipkorn

Nofisat Ismaila

Barbara Burtness